Zompola Christina, Palaiodimou Lina, Voumvourakis Konstantinos, Stefanis Leonidas, Katsanos Aristeidis H, Sandset Else C, Boviatsis Estathios, Tsivgoulis Georgios
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
First Department of Neurology, "Aeginition" University Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
J Clin Med. 2024 Mar 29;13(7):1981. doi: 10.3390/jcm13071981.
The management of blood pressure variability (BPV) in acute stroke presents a complex challenge with profound implications for patient outcomes. This narrative review examines the role of BPV across various stages of acute stroke care, highlighting its impact on treatment strategies and prognostic considerations. In the prehospital setting, while guidelines lack specific recommendations for BP management, emerging evidence suggests a potential link between BPV and outcomes. Among ischaemic stroke patients who are ineligible for reperfusion therapies, BPV independently influences functional outcomes, emphasising the need for individualised approaches to BP control. During intravenous thrombolysis and endovascular therapy, the intricate interplay between BP levels, recanalisation status, and BPV is evident. Striking a balance between aggressive BP lowering and avoiding hypoperfusion-related complications is essential. Intracerebral haemorrhage management is further complicated by BPV, which emerges as a predictor of mortality and disability, necessitating nuanced BP management strategies. Finally, among patients with acute subarachnoid haemorrhage, increased BPV may be correlated with a rebleeding risk and worse outcomes, emphasizing the need for BPV monitoring in this population. Integration of BPV assessment into clinical practice and research protocols is crucial for refining treatment strategies that are tailored to individual patient needs. Future studies should explore novel interventions targeting BPV modulation to optimise stroke care outcomes.
急性卒中患者血压变异性(BPV)的管理是一项复杂的挑战,对患者预后有着深远影响。本叙述性综述探讨了BPV在急性卒中治疗各阶段的作用,强调其对治疗策略和预后考量的影响。在院前环境中,虽然指南缺乏针对血压管理的具体建议,但新出现的证据表明BPV与预后之间可能存在联系。在不符合再灌注治疗条件的缺血性卒中患者中,BPV独立影响功能预后,这凸显了采取个体化血压控制方法的必要性。在静脉溶栓和血管内治疗期间,血压水平、再通状态和BPV之间复杂的相互作用显而易见。在积极降低血压与避免低灌注相关并发症之间取得平衡至关重要。BPV使脑出血的管理更加复杂,它是死亡率和残疾的预测指标,因此需要有细致入微的血压管理策略。最后,在急性蛛网膜下腔出血患者中,BPV升高可能与再出血风险及更差的预后相关,这强调了对该人群进行BPV监测的必要性。将BPV评估纳入临床实践和研究方案对于完善根据个体患者需求定制的治疗策略至关重要。未来的研究应探索针对BPV调节的新型干预措施,以优化卒中治疗效果。